Literature DB >> 7870105

Evaluation of the cardiomyopathy in Becker muscular dystrophy.

G Nigro1, L I Comi, L Politano, F M Limongelli, V Nigro, M L De Rimini, M A Giugliano, V R Petretta, L Passamano, B Restucci.   

Abstract

To evaluate the features and the course of cardiomyopathy in Becker muscular dystrophy, 68 patients--identified by clinical assessment and by reduced dystrophin labeling and/or DNA analysis--were followed in the years 1976-1993, for periods ranging from 3 to 18 years (mean 8). Patients periodically underwent clinical, electrocardiographic, echocardiographic, nuclear, and radiological assessments. Preclinical cardiac involvement was found in 67.4% of patients under 16 years of age, decreasing to 30% in patients older than 40. Clinically evident cardiomyopathy was found in 15% of patients under 16 years of age, increasing to 73% in patients older than 40. A real, dilated cardiomyopathy is the most frequent type of myocardial involvement after the age of 20. Results show that the severity of cardiac involvement can be unrelated to the severity of skeletal muscle damage and confirm that cardiac dysfunction is a primary feature of Becker muscular dystrophy.

Entities:  

Mesh:

Year:  1995        PMID: 7870105     DOI: 10.1002/mus.880180304

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  34 in total

1.  Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients.

Authors:  Ge Nigro; G Nigro; L Politano; L Santangelo; V R Petretta; L Passamano; F Panico; F De Luca; A Montefusco; L I Comi
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

2.  Secondary and Infiltrative Cardiomyopathies.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

3.  Cardiac involvement in patients with myotonic dystrophy, Becker's muscular dystrophy and mitochondrial myopathy.

Authors:  J Finsterer; C Stöllberger; H Keller; J Slany; B Mamoli
Journal:  Herz       Date:  1997-04       Impact factor: 1.443

Review 4.  Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.

Authors:  Harjot K Saini-Chohan; Ryan W Mitchell; Frédéric M Vaz; Teresa Zelinski; Grant M Hatch
Journal:  J Lipid Res       Date:  2011-11-07       Impact factor: 5.922

5.  Is heart rate variability a valid parameter to predict sudden death in patients with Becker's muscular dystrophy?

Authors:  E Ammendola; V Russo; L Politano; L Santangelo; R Calabrò
Journal:  Heart       Date:  2006-11       Impact factor: 5.994

Review 6.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

Review 7.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 8.  Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.

Authors:  N Cohen; F Muntoni
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

9.  A case of Becker muscular dystrophy with early manifestation of cardiomyopathy.

Authors:  Ki Hyun Doo; Hye Won Ryu; Seung Soo Kim; Byung Chan Lim; Hui Hwang; Ki Joong Kim; Yong Seung Hwang; Jong-Hee Chae
Journal:  Korean J Pediatr       Date:  2012-09-14

10.  Dystrophinopathy presenting with arrhythmia in an asymptomatic 34-year-old man: a case report.

Authors:  Seth E Wakefield; Elliot L Dimberg; Steven A Moore; Brian S Tseng
Journal:  J Med Case Rep       Date:  2009-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.